UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 3, 2007
THE COOPER COMPANIES, INC.
(Exact name of registrant as specified in its charter)
Delaware | 1-8597 | 94-2657368 | ||
(State or other jurisdiction of incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
6140 Stoneridge Mall Road, Suite 590, Pleasanton, California 94588
(Address of principal executive offices)
(925) 460-3600
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
ITEM 5.02. | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On April 3, 2007, The Cooper Companies, Inc. issued a press release to announce management changes with Robert S. Weiss, currently Coopers executive vice president and chief operating officer, assuming additional duties as president of CooperVision, Inc., reporting to A. Thomas Bender, Coopers chairman and chief executive officer. Mr. Weiss will have direct responsibility for CooperVisions worldwide business and for CooperSurgical, the Companys womens health medical device business. Steven M. Neil, currently vice president and chief financial officer, has been named executive vice president and chief financial officer, reporting to Mr. Weiss. His expanded role will include overseeing the integration of CooperVisions financial and information technology functions into the Companys headquarters operations. Gregory A. Fryling, currently president of CooperVision, Inc., will be leaving CooperVision to pursue other opportunities.
The release also said that Mr. Bender has expressed his desire to relinquish his role as chief executive officer by the end of 2007, but expects to have a continuing role in the Company thereafter. Coopers Board has been engaged in a succession planning process and is considering both internal and external candidates for chief executive officer in its search process.
A copy of this release is attached as Exhibit 99.1 and incorporated herein by reference.
Internet addresses in the release are for information purposes only and are not intended to be hyperlinks to other Cooper Companies information.
ITEM 9.01. | Financial Statements and Exhibits. |
(d) | Exhibits. |
Exhibit No. | Description | |
99.1 | Press Release dated April 3, 2007, of The Cooper Companies, Inc. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
THE COOPER COMPANIES, INC. | ||
By | /s/ Rodney E. Folden | |
Rodney E. Folden | ||
Corporate Controller (Principal Accounting Officer) |
Dated: April 3, 2007
EXHIBIT INDEX
Exhibit No. | Description | |
99.1 | Press Release dated April 3, 2007, of The Cooper Companies, Inc. |
Exhibit 99.1
|
||||
NEWS RELEASE | 21062 Bake Parkway | |||
Lake Forest, CA 92630 | ||||
CONTACT: |
888-822-2660 | |||
Fax: 949-597-0662 | ||||
Norris Battin |
||||
The Cooper Companies, Inc. |
||||
ir@coopercompanies.com |
||||
FOR IMMEDIATE RELEASE |
THE COOPER COMPANIES ANNOUNCES RESTRUCTURING AND MANAGEMENT CHANGES
LAKE FOREST, Calif., April 3, 2007 The Cooper Companies, Inc. (NYSE:COO) said today that as part of the continuing integration of Ocular Sciences, Inc., which was acquired in January of 2005, it is combining its CooperVision and Cooper Companies headquarters operations and announced the following management changes.
| Robert S. Weiss, currently Coopers executive vice president and chief operating officer has assumed additional duties as president of CooperVision, Inc., reporting to A. Thomas Bender, Coopers chairman and chief executive officer. Weiss will have direct responsibility for CooperVisions worldwide business and for CooperSurgical, the Companys womens health medical device business. |
| Steven M. Neil, currently vice president and chief financial officer, has been named executive vice president and chief financial officer, reporting to Weiss. His expanded role will include overseeing the integration of CooperVisions financial and information technology functions into the Companys headquarters operations. |
| Gregory A. Fryling, currently president of CooperVision, Inc., will be leaving CooperVision to pursue other opportunities. |
Commenting on the new structure, Bender said, We are nearing the completion of our three-year integration plan following the acquisition of Ocular. Combining CooperVision and The Cooper Companies headquarters is an important step in streamlining our business.
I want to personally thank Greg Fryling for 22 years of service and an outstanding job throughout the Ocular integration process. Over the years, Greg played a key role in CooperVisions business development program leading our efforts to acquire Aspect Vision, Biocompatibles and Ocular Sciences. We wish him every success in the future.
Separately, the Company said that Bender has expressed his desire to relinquish his role as chief executive officer by the end of 2007, but expects to have a continuing role in the Company thereafter. Coopers Board has been engaged in a succession planning process and is considering both internal and external candidates for chief executive officer in its search process.
Corporate Information
The Cooper Companies, Inc. manufactures and markets specialty healthcare products through its CooperVision and CooperSurgical units. Corporate offices are in Lake Forest and Pleasanton, Calif. The World Wide Web address is www.coopercos.com. A toll free interactive telephone system at 1-800-334-1986 provides stock quotes, recent press releases and financial data.
CooperVision manufactures and markets contact lenses. Headquartered in Pleasanton, Calif., it manufactures in Juana Diaz, Puerto Rico, Norfolk, Va., Rochester, N.Y., Adelaide, Australia, Hamble and Hampshire England, Ligny-en-Barrios, France, and Madrid, Spain. Its Web address is www.coopervision.com.
CooperSurgical manufactures and markets diagnostic products, surgical instruments and accessories to the womens healthcare market. With headquarters and manufacturing facilities in Trumbull and Orange, Conn., and in Pasadena, Calif., Houston, Texas, North Normandy, Ill., Williston, Vt., Fort Atkinson, Wis., Montreal and Berlin. Its Web address is www.coopersurgical.com
The information on Coopers Web sites and its interactive telephone system are not part of this announcement.
# # #